Angiotensin Receptor-Neprilysin Inhibition for Doxorubicin-Mediated Cardiotoxicity Time for a Paradigm Shift

被引：0
|
作者：
Hahn, Virginia S. [1 ]
Sharma, Kavita [1 ]
机构：
[1] Johns Hopkins Univ, Sch Med, Div Cardiol, Baltimore, MD USA
来源：
JACC: CARDIOONCOLOGY | 2020年 / 2卷 / 05期
关键词：
anthracycline; cardio-oncology; echocardiography; fibrosis; heart failure; matrix metalloproteinase; molecular imaging; neprilysin preclinical study; treatment;
D O I：
10.1016/j.jaccao.2020.10.006
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：788 / 790
页数：3
相关论文
共 50 条
  • [31] Acute Tubular Necrosis Associated with Angiotensin Receptor-neprilysin Inhibitor
    Kim, Moo Jun
    Jang, Ha Nee
    Song, Haa-Na
    Lee, Jong Sil
    Kang, Min Gyu
    INTERNAL MEDICINE, 2022, 61 (10) : 1573 - 1576
  • [32] Narrative review in the current role of angiotensin receptor-neprilysin inhibitors
    Rodriguez, Jose B. Cruz
    Cu, Cameron
    Siddiqui, Tariq
    ANNALS OF TRANSLATIONAL MEDICINE, 2021, 9 (06)
  • [33] Targeting a Gpcr, Prokineticin Receptor-1, Protects Heart Against Doxorubicin-Mediated Cardiotoxicity
    Nebigil, Canan G.
    Gasser, Adeline
    Charavin, Marine
    Escoubet, Brigitte
    Audebrand, Anais
    Chan, Michael W.
    Cardinale, Daniela
    Desaubry, Larent
    CIRCULATION, 2018, 138
  • [34] Is it time to adopt angiotensin receptor-neprilysin inhibitors (ARNI) therapy as standard of care for the management of hypertension?
    Ali, Ayan
    Ortega-Legaspi, Juan M.
    ANNALS OF PALLIATIVE MEDICINE, 2022,
  • [35] Terminalia chebula retz: A prospective agent in reducing the doxorubicin-mediated cardiotoxicity
    Aamina, M.
    Alhowail, Ahmad
    Aldubayan, Maha
    Rabbani, Syed Imam
    PHARMACOGNOSY RESEARCH, 2020, 12 (03): : 219 - 224
  • [36] Angiotensin Receptor-Neprilysin Inhibition (ARNI) Therapy and Reverse Remodeling in Heart Failure With Reduced Ejection Fraction
    Drazner, Mark H.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2019, 322 (11): : 1051 - 1053
  • [37] Angiotensin receptor-neprilysin inhibition in patients with acute decompensated heart failure: an expert consensus position paper
    Argyrios Ntalianis
    Christina Chrysohoou
    George Giannakoulas
    Grigorios Giamouzis
    Apostolos Karavidas
    Aikaterini Naka
    Constantinos H. Papadopoulos
    Sotirios Patsilinakos
    John Parissis
    Dimitrios Tziakas
    John Kanakakis
    Heart Failure Reviews, 2022, 27 : 1 - 13
  • [38] Mice lacking mitochondrial ferritin are more sensitive to doxorubicin-mediated cardiotoxicity
    Maccarinelli, Federica
    Gammella, Elena
    Asperti, Michela
    Regoni, Maria
    Biasiotto, Giorgio
    Turco, Emilia
    Altruda, Fiorella
    Lonardi, Silvia
    Cornaghi, Laura
    Donetti, Elena
    Recalcati, Stefania
    Poli, Maura
    Finazzi, Dario
    Arosio, Paolo
    Cairo, Gaetano
    JOURNAL OF MOLECULAR MEDICINE-JMM, 2014, 92 (08): : 859 - 869
  • [39] Angiotensin receptor-neprilysin inhibition in patients with acute decompensated heart failure: an expert consensus position paper
    Ntalianis, Argyrios
    Chrysohoou, Christina
    Giannakoulas, George
    Giamouzis, Grigorios
    Karavidas, Apostolos
    Naka, Aikaterini
    Papadopoulos, Constantinos H.
    Patsilinakos, Sotirios
    Parissis, John
    Tziakas, Dimitrios
    Kanakakis, John
    HEART FAILURE REVIEWS, 2022, 27 (01) : 1 - 13
  • [40] Angiotensin Receptor-Neprilysin Inhibition Therapy and Improved Exercise Parameters in Heart Failure with Reduced Ejection Fraction
    Schwartzmann, Pedro
    ARQUIVOS BRASILEIROS DE CARDIOLOGIA, 2020, 115 (05) : 828 - 829
12345